Allergy & Immunology Research
Advancing Allergy Clinical Research
Millions of people worldwide suffer from seasonal allergies, asthma, food allergies, and chronic immune-related conditions. CenExel partners with sponsors to advance innovative allergy and immunology treatments through high-quality clinical research across diverse patient populations.
Specialized Allergy & Immunology Clinical Research
CenExel provides specialized expertise in allergy and immunology clinical trials, supporting sponsors with experienced investigators, patient recruitment strategies, and operational excellence. Our research teams help accelerate studies focused on respiratory allergies, food allergies, asthma, eczema, and immune-related disorders.
Accelerate Patient Enrollment
High-Quality Clinical Operations
Allergy & Immunology Conditions We Research
Our allergy and immunology research sites support a broad range of conditions from seasonal allergies and asthma to chronic inflammatory and immune disorders.
- Seasonal Allergies
- Allergic Rhinitis
- Asthma
- Food Allergies
- Atopic Dermatitis (Eczema)
- Chronic Urticaria
- Sinusitis
- Pediatric Allergies
Why Sponsors Choose CenExel for Allergy Research
CenExel delivers scientific expertise, strong patient recruitment strategies, and operational efficiency to support successful allergy and immunology clinical trials.
01
Strong Patient Recruitment
Our teams connect with highly targeted patient populations for faster enrollment and improved retention.
02
Experienced Investigators
Board-certified investigators and research specialists support a wide range of allergy indications.
03
Diverse Patient Populations
Our nationwide site network helps sponsors reach diverse demographic groups and pediatric populations.
04
Efficient Study Execution
CenExel sites are focused on rapid startup timelines, protocol compliance, and data quality.
Supported Allergy Trial Phases
CenExel supports early and late-phase allergy and immunology research, including proof-of-concept studies through Phase IV post-market trials.
Active across all phases
- Phase I
- Phase II
- Phase III
- Phase IV
Our experienced research teams support biologics, respiratory therapies, immunotherapies, and emerging allergy treatment programs across multiple therapeutic areas.
Allergy Research Task Force
CenExel supports a wide range of allergy and immunology studies including asthma, respiratory diseases, food allergies, eczema, pediatric indications, and inflammatory conditions.






